Preprint
P2Y12 Inhibitor Utilization for Acute Coronary Syndrome in the Elderly: A Provincial Analysis From 2008 to 2018
Abstract
Background Guidelines recommend acetylsalicylic acid (ASA) and ticagrelor following acute coronary syndrome (ACS), but appropriate prescription practices lag. We analyzed the impact of government medication approval, national guideline updates, and publicly funded drug coverage plans on P2Y12 inhibitor utilization.
Methods Accessing provincial databases, we obtained data for elderly ACS patients in Ontario, Canada between 2008 and 2018. Using an …
Authors
Gupta S; Belley-Cote EP; Eqbal A; McEwen C; Basha A; Wu N; Cerasuolo J; Mehta S; Schwalm J-D; Whitlock RP
DOI
10.21203/rs.3.rs-97757/v1
Preprint server
Research Square